首页> 外文期刊>Japanese Journal of Ophthalmology >Posterior?subtenon?infusion of triamcinolone acetonide as adjunctive treatment to panretinal photocoagulation using pattern scan laser for diabetic retinopathy
【24h】

Posterior?subtenon?infusion of triamcinolone acetonide as adjunctive treatment to panretinal photocoagulation using pattern scan laser for diabetic retinopathy

机译:后粒子?亚乙二醇?用图案扫描激光用于糖尿病视网膜病变的辅助治疗抗菊酮酮乙酮作为辅助治疗

获取原文
获取原文并翻译 | 示例
           

摘要

Purpose To estimate the effect of sub-Tenon’s capsule triamcinolone acetonide injection (STTA) combined with panretinal photocoagulation (PRP) using pattern scan laser (PSL) for high risk non-proliferative diabetic retinopathy (NPDR), in terms of the inflammation and the progression of diabetic macular edema (DME). Study design Retrospective comparative analysis. Methods NPDR patients who underwent PRP using PSL with (STTA+PSL group, n=24) or without (PSL group, n=19) pretreatment of STTA were enrolled. We measured anterior flare intensity (AFI) and central retinal thickness (CRT) at day of STTA (day 0), and at 1, 3, 7, 11 and 15 weeks. Results The CRT of the STTA+PSL group was significantly lower than that of the PSL group at 7 (308.15±69.16?μm versus 340.21±77.91?μm, p = 0.04), 11 (283.8±60.75?μm versus 335.7±67.70?μm, p = 0.01) and 15 weeks (281.13±35.29?μm versus 316.58±54.89?μm, p = 0.02). AFI levels in the STTA+PSL group were significantly lower than those in the PSL group at 11 (10.47±3.40 versus 15.85±8.38, p = 0.007) and 15 weeks (11.38±3.31 versus 14.37±3.85, p = 0.009). The significant improvement in CRT from baseline was noticed through the observational periods in STTA+PSL group, but not in the PSL group. Conclusion Pretreatment of STTA has the potential to not only prevent the worsening of DME, but also reduce the CRT and AFI of eyes with NPDR after PRP using PSL.
机译:目的,估算亚肾盂囊脂合酶乙酮酮胺注射(STTA)与PANRetinal光凝(PRP)相结合的使用图案扫描激光(PSL),在炎症和进展方面糖尿病黄斑水肿(DME)。研究设计回顾性比较分析。方法注册了使用PSL(STTA + PSL组,N = 24)或没有(PSL组,N = 19)STTA的预处理的PRP的NPDR患者进行了患者。我们在STTA(第0天)的日期(第0天)下测量前辐射强度(AFI)和中央视网膜厚度(CRT),以及在1,3,7,11和15周。结果STTA + PSL组的CRT显着低于PSL组的7(308.15±69.16Ω,μm,p = 0.04),11(283.8±60.75Ω,p = 0.04),11(283.8±60.75×75.7±67.70? μm,p = 0.01)和15周(281.13±35.29≤μm与316.58±54.89ΩΩmp= 0.02)。 STTA + PSL组中的AFI水平明显低于PSL组的11(10.47±3.40与15.85±8.38,P = 0.007)和15周(11.38±3.31与14.37±3.85,P = 0.009)。通过STTA + PSL组的观察期,注意到基线CRT的显着改善,但不在PSL组中。结论STTA的预处理有潜力不仅可以防止DME的恶化,还可以使用PSL在PRP后用NPDR减少眼睛的CRT和AFI。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号